Literature DB >> 16979032

Pathology and pathogenesis of infective endocarditis in native heart valves.

Gaetano Thiene1, Cristina Basso2.   

Abstract

Infective endocarditis is an endovascular microbial infection of cardiovascular structures, including large intrathoracic vessels and intracardiac foreign bodies. The characteristic lesions consist of vegetations composed of platelets, fibrin, microorganisms, and inflammatory cells, as well as leaflet disruption. The commonly accepted pathogenetic theory is herein reported, from endothelial injury with deposition of noninfective sterile thrombotic vegetations to transient bacteremia with microorganism adhesion (injury-thrombus-infection theory). This review addresses the pathology of native valve endocarditis, including local (valvular and perivalvular destruction) and distal (embolism, metastatic infection, and septicemia) complications. Old and new cardiac conditions and patients at risk, predisposing to the occurrence of infective endocarditis, are then discussed. Particular emphasis is given to hidden bicuspid aortic valve and the need of early carrier identification for prophylaxis.

Entities:  

Mesh:

Year:  2006        PMID: 16979032     DOI: 10.1016/j.carpath.2006.05.009

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  33 in total

1.  Transmural arteritis with subsequent brain infarct as a rare complication of inflammatory head and neck disease : considering endovascular treatment options.

Authors:  F Dorn; A Milkereit; P Berlit; T Liebig
Journal:  Clin Neuroradiol       Date:  2010-06-18       Impact factor: 3.649

2.  Cardiac complications of infective endocarditis.

Authors:  John R Ebright
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

3.  Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein.

Authors:  Jorien Claes; Thomas Vanassche; Marijke Peetermans; Laurens Liesenborghs; Christophe Vandenbriele; Karen Vanhoorelbeke; Dominique Missiakas; Olaf Schneewind; Marc F Hoylaerts; Ruth Heying; Peter Verhamme
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

Review 4.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

Review 5.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

6.  Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.

Authors:  Casey J Holliday; Randall F Ankeny; Hanjoong Jo; Robert M Nerem
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

7.  Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.

Authors:  Andrew J Kim; Na Xu; Kazuhiro Umeyama; Alexia Hulin; Sithara Raju Ponny; Ronald J Vagnozzi; Ellis A Green; Paul Hanson; Bruce M McManus; Hiroshi Nagashima; Katherine E Yutzey
Journal:  Circulation       Date:  2020-01-13       Impact factor: 29.690

8.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

Review 9.  Glycan recognition at the saliva - oral microbiome interface.

Authors:  Benjamin W Cross; Stefan Ruhl
Journal:  Cell Immunol       Date:  2018-08-18       Impact factor: 4.868

10.  Effectiveness of Thrombolytic Therapy in Acute Embolic Stroke due to Infective Endocarditis.

Authors:  Siva P Sontineni; Aryan N Mooss; Venkata G Andukuri; Susan Marie Schima; Dennis Esterbrooks
Journal:  Stroke Res Treat       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.